At some point in most arthritic dogs' lives, the combination of weight management, exercise modification, and joint supplementation is not enough to control pain and maintain quality of life. That is when prescription NSAIDs enter the conversation.
NSAIDs are the most commonly prescribed medications for canine arthritis pain. They are effective, well-studied, and for many dogs they are genuinely life-changing. They are also not without risk — and understanding both the benefits and the risks allows you to make informed decisions alongside your veterinarian about when, whether, and how to use them.
Dog Arthritis: Causes, Stages, and What You Can Actually Do About It →
How Canine NSAIDs Work
NSAIDs reduce pain and inflammation by inhibiting cyclooxygenase (COX) enzymes that produce prostaglandins — chemical mediators responsible for inflammation, pain, and fever at the joint site. By reducing prostaglandin production, NSAIDs decrease the inflammatory response that produces joint pain and progressive cartilage damage.
There are two primary COX enzymes: COX-1 (involved in normal protective functions — stomach lining maintenance, kidney blood flow regulation, platelet function) and COX-2 (involved primarily in inflammatory processes). The selectivity of an NSAID for COX-2 over COX-1 determines its side effect profile — more COX-2 selective drugs tend to produce fewer gastrointestinal side effects.
The Most Commonly Prescribed Canine NSAIDs
All medication details below must be verified against current prescribing information before publication. Dosing and availability are subject to change.
Carprofen (Rimadyl)
Dosing: 4.4 mg/kg (2 mg/lb) once daily, or 2.2 mg/kg (1 mg/lb) twice daily. Give with food to reduce GI side effects.
Strengths: The most widely prescribed canine NSAID with the longest track record. Well-studied, effective for mild-to-moderate arthritis pain. Generics — Novox, Vetprofen, Carprieve, Quellin, Norocarp, and others, including a new generic soft chewable FDA-approved in September 2024 — cost up to 80% less than brand-name Rimadyl at equivalent bioavailability.
Considerations: GI side effects (vomiting, diarrhea, appetite loss) are the most common. A rare idiosyncratic hepatopathy (liver reaction) occurs in approximately 1 in 5,000 dogs — unpredictable and not dose-dependent. Baseline blood work before starting, recheck at 2–4 weeks, then every 3–6 months on long-term use. Never combine with other NSAIDs or corticosteroids.
Meloxicam (Metacam)
Dosing: Loading dose of 0.09 mg/lb (0.2 mg/kg) on day 1 only; maintenance dose of 0.045 mg/lb (0.1 mg/kg) once daily thereafter. The dosing syringe is calibrated by body weight. Shake the bottle before each use. For dogs under 10 lbs, administer onto food only — never directly into the mouth — to prevent accidental overdose.
Strengths: Liquid formulation allows precise micro-dose titration. Once-daily maintenance dosing after the loading dose. The most widely used veterinary NSAID globally, with a long track record across many countries.
Considerations: Same GI and renal monitoring requirements as other NSAIDs. Do NOT use in cats — repeated use is associated with acute renal failure and death. The oral suspension is contraindicated in cats (FDA label).
Grapiprant (Galliprant)
Dosing: 2 mg/kg (0.9 mg/lb) once daily. Best absorbed on an empty stomach — food reduces peak blood concentration approximately 4-fold. If GI upset occurs, can be given with a small amount of food.
Strengths: Blocks the EP4 prostaglandin receptor specifically rather than inhibiting COX enzymes broadly. This spares COX-1 protective functions (stomach lining, kidney blood flow, platelet function), giving it a better GI and renal safety profile than traditional NSAIDs. FDA-approved specifically for canine OA pain. Not approved for cats.
Considerations: More expensive than generic carprofen or meloxicam. Some dogs respond less strongly than they do to traditional COX-inhibiting NSAIDs. Not studied in dogs under 9 months, under 8 lbs, or with cardiac disease.
Beyond NSAIDs: Newer Options
Librela (bedinvetmab) — FDA approved May 2023
A monthly subcutaneous injectable monoclonal antibody that targets nerve growth factor (NGF) — a protein involved in pain signaling. Librela is not an NSAID and does not affect COX enzymes, stomach lining, or kidney function. It provides consistent monthly pain control without daily dosing, administered by a veterinarian. More than one million US dogs have been treated since its launch in October 2023.
Important label update (February 2025): The FDA issued a "Dear Veterinarian" letter and Zoetis updated the US label based on post-approval adverse event reports, which included neurologic signs (ataxia, seizures, paresis, recumbency), urinary incontinence, polyuria and polydipsia, and in some cases death. These events are reported but their frequency relative to the large treated population remains under evaluation. Librela remains FDA-approved and available. Discuss the benefit-risk profile with your veterinarian, particularly for dogs with pre-existing neurologic conditions.
Adequan (polysulfated glycosaminoglycan) — FDA approved, disease-modifying
An injectable prescription PSGAG (polysulfated glycosaminoglycan) that inhibits cartilage-degrading enzymes and supports joint fluid quality. Unlike NSAIDs, Adequan is classified as a disease-modifying osteoarthritis drug (DMOAD) — it acts on the underlying cartilage rather than just managing symptoms. The approved protocol is 2 mg/lb by intramuscular injection twice weekly for four weeks (8 injections total), with many vets prescribing longer-term maintenance dosing when clinical signs return. Adequan reaches the joint cartilage within two to three days of injection. It complements both NSAIDs and joint supplements.
Supplements and Medication: Better Together
MoveGuard Adult provides the daily joint support that complements prescription pain management — reducing NSAID requirements and supporting cartilage between doses.
Shop MoveGuard Adult →The Risks: What Monitoring Is Needed
Baseline blood work: complete blood count, chemistry panel including liver enzymes, kidney values, and urinalysis. This establishes normal values for comparison.
Recheck blood work to assess early liver or kidney response to the medication. Carprofen: recheck at 10–14 days per some sources, or 2–4 weeks — follow your vet's specific protocol.
Blood work and urinalysis to monitor liver, kidney, and GI function. This is the standard recommendation from the American Animal Hospital Association for long-term NSAID use.
Vomiting, diarrhea, dark or tarry stool (GI bleeding), decreased appetite, increased thirst or urination, lethargy, or jaundice (yellowing of gums or eyes). Report any of these to your vet immediately.
The risks of NSAIDs are real but manageable with proper monitoring. The majority of dogs tolerate NSAIDs well for years. The monitoring protocol exists to catch the small percentage of dogs who develop adverse effects early enough to prevent serious harm.
How Supplements Fit Alongside NSAIDs
Joint supplements and NSAIDs are not competing approaches — they are complementary layers that address different aspects of joint disease. NSAIDs reduce pain and inflammation (the symptom layer). Supplements support cartilage maintenance and provide additional anti-inflammatory compounds (the structural and preventive layer). Multiple published studies have shown that dogs receiving both NSAID treatment and joint supplementation have better outcomes than dogs on either alone.
Starting MoveGuard Adult alongside NSAID therapy may allow a reduction in the NSAID dose over time — under veterinary guidance — reducing the side effect risk while maintaining pain control. This is not guaranteed for every dog, but it is a commonly reported outcome when comprehensive joint management is implemented.
Dog Joint Supplements: Do They Actually Work? What the Veterinary Research Says →
Critical Warning: Never Give Human NSAIDs to Dogs
- Ibuprofen (Advil, Motrin): Toxic to dogs. Causes GI ulceration and kidney failure at doses commonly used in humans.
- Naproxen (Aleve): Extremely toxic to dogs. Even a single tablet can cause fatal GI bleeding.
- Acetaminophen (Tylenol): Not an NSAID but frequently confused with one. Extremely toxic to dogs — causes liver failure and methemoglobinemia.
- Aspirin: Occasionally used under veterinary direction at very low doses, but carries significant GI risk and interacts with other NSAIDs. Never give aspirin without veterinary guidance, and NEVER give aspirin alongside a prescription NSAID.
If your dog is in pain, call your vet for appropriate prescription pain management. Do not give any human pain medication without explicit veterinary instruction.
Frequently Asked Questions
Many dogs take NSAIDs safely for years with proper monitoring. Long-term use requires the biannual blood work monitoring protocol to catch any organ effects early. For dogs who need chronic pain management, newer options (Galliprant for better GI safety, Librela for non-NSAID monthly pain control) may be better suited to long-term use than traditional NSAIDs.
There is no interaction between MoveGuard Adult and any canine NSAID — they can be given together. The nuance with Galliprant: it is best absorbed on an empty stomach (food reduces peak concentration ~4-fold), so ideally give Galliprant before a meal and give MoveGuard with the meal. If Galliprant causes GI upset on an empty stomach, your vet may advise giving it with a small amount of food.
If your dog's mobility and comfort are well-managed with supplementation, weight management, and exercise alone, prescription NSAIDs are not necessary. NSAIDs are appropriate when the non-pharmaceutical approaches are insufficient to maintain quality of life. Many dogs with mild-to-moderate arthritis (Stage 1–2) do well on supplements and lifestyle management without prescription medication. The NSAID is reserved for when those measures are not enough.
The Foundation That Makes Every Treatment More Effective
MoveGuard Adult: the daily joint support that complements medication, exercise, and weight management.
Shop MoveGuard Adult →
